Innoviva
INVA
106 hedge funds and large institutions have $1.82B invested in Innoviva in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
56% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 32
18% more capital invested
Capital invested by funds: $1.54B → $1.82B (+$272M)
12% more call options, than puts
Call options by funds: $4.61M | Put options by funds: $4.13M
4% less funds holding
Funds holding: 110 → 106 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$24.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$9.24M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$7.04M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.87M |
| 5 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$5.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$13.7M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$8.59M |
| 3 |
PCM
Proxima Capital Management
New York
|
-$6.8M |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.08M |
| 5 |
Morgan Stanley
New York
|
-$3.11M |
INVA Hedge Fund Activity: Q2 2015 in Review
106 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q2 2015, worth a combined $1.82B — up 18% from $1.54B a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of INVA and 7 opened new positions — a net loss of 4 holders — while 32 trimmed existing stakes and 50 added.
The largest buyer was Iridian Asset Management, adding an estimated $24.3M. The largest seller was Invesco, cutting an estimated $13.7M.
- 106 institutional investors held Innoviva (INVA) as of Q2 2015, down from 110 in Q1 2015.
- Funds reported $1.82B of Innoviva stock for Q2 2015, up 18% quarter-over-quarter.
- 7 funds opened new Innoviva positions in Q2 2015 and 11 closed out, a net change of -4 holders.
- The largest Innoviva buyer in Q2 2015 was Iridian Asset Management, an estimated $24.3M added.
- The largest Innoviva seller in Q2 2015 was Invesco, an estimated $13.7M sold.
Based on aggregated 13F filings for Q2 2015.